eli lilly and tirzepatide launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Patients Taking Experimental Obesity Drug
Description
Initial recommended dose: 5 mcg/min, increasing in increments of 5 mcg/min every 3 to 5 minutes up to 20 mcg/min
If you plan to draw multiple doses from the same vial over days or weeks, you must use bacteriostatic water
After opening, users can store it at room temperature for up to 56 days
In the SURPASS trials, participants were taking at least 1,500 mg of metformin daily
Our programs are designed to be transparent and comprehensive
#OptimizingG&Kd, guide us toward safer, more effective therapies
